Pr François Ghiringhelli
- Spécialité
- Oncologue médical, expert digestif
- Hôpital
- Centre Georges-François Leclerc (Dijon)
- Derniers articles
-
- Immunohistochemistry Resolves Indeterminate MTAP Deletion Calls from Exome Sequencing: A Pan-Cancer Concordance Study. (23 sept. 2026)
- An integrated Phase II/III randomized study comparing durvalumab and tremelimumab ± Hepatic ArteriaL infusion chemotherapy with GEMOX in hepatocellular Carcinoma with high tumor burdEn - ALICE (PRODIGE89 - UCGI44 - ALICE). (14 sept. 2026)
- Human endogenous retroviruses as immune-related prognostic biomarkers in pancreatic cancer. (20 août 2026)
- Subclinical cholestasis is a hallmark of gut dysbiosis causing resistance to cancer immunotherapy. (10 août 2026)
- Usability and relevance of specialized population-based cancer registry data in externally controlled trials. (5 août 2026)